Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Safety and Dose-Finding of rhRlx in Compensated CHF
NCT00259116Phase 2Completed
- Start
- Nov 2005
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of serelaxin in heart failure (HF). Started Nov 2005; status: completed.
02
Drugs
serelaxin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00259116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259116.